Skip to main content
. 2022 Feb 11;58(2):271. doi: 10.3390/medicina58020271

Table 2.

Variables with statistically significant differences among diabetic patients infected with the two species of Proteeae.

Variable Sample of Diabetic Patients Infected with P. mirabilis
n1 = 75
Sample of Diabetic Patients Infected with P. stuartii
n2 = 18
p Value
Number of antibiotics [median, IQR] 2 (2) 5 (3) <0.001
Days with CVC [median, IQR] 2 (12) 16.50 (20) 0.032
Days with UC [median, IQR] 0 (10) 19 (19) 0.019
Number of antibiotics with resistance/pathogen [median, IQR] 1(4) 9 (5) <0.001
Anti-biotherapy prior to ICU [n, %] 9 (12.00) 8 (44.44) 0.003
Mechanical ventilation [n, %] 18 (24.00) 13 (72.22) <0.001
Urinary catheter [n, %] 31 (41.33) 15 (83.33) 0.001
Tracheostomy [n, %] 8 (10.67) 10 (55.55) <0.001
Blood transfusions [n, %] 17 (22.67) 11 (61.11) 0.001
Nasogastric nutrition [n, %] 18 (24.00) 15 (83.33) <0.001
Mechanical ventilation 0 h [n, %] 57 (76.00) 5 (27.77) <0.001
Mechanical ventilation ≥ 96 h [n, %] 16 (21.33) 13 (72.22) <0.001
Discharge status - Deceased [n, %] 20 (26.67) 9 (50.00) 0.054
HCAI [n, %] 17 (22.67) 13 (72.22) <0.001
Blood culture [n, %] 3 (4.00) 6 (33.33) 0.001
Catheter tip [n, %] 2 (2.67) 6 (33.33) <0.001
Wound swab [n, %] 48 (64.00) 3 (16.67) <0.001
WT phenotype [n, %] 24 (32.00) 0 (0) 0.005
DTR phenotype [n, %] 0 (0) 7 (38.89) <0.001
MDR phenotype [n, %] 26 (34.67) 18 (100) <0.001
XDR phenotype [n, %] 3 (4.00) 11 (61.11) <0.001
Aminoglycoside resistance [n, %] 3 (4.00) 9 (50.00) <0.001
ESBL [n, %] 6 (8.00) 9 (50.00) <0.001
Carbapenem resistance [n, %] 1 (1.33) 12 (66.67) <0.001
Fluoroquinolone resistance [n, %] 10 (13.33) 17 (94.44) <0.001
Sulphonamide resistance [n, %] 41 (54.67) 18 (100) <0.001

Legend: n, number; IQR, interval between quartiles; CVC, central venous catheter; ICU, intensive care unit; h, hour; HCAI, healthcare associated infections; WT, wild type; DTR, difficult-to-treat resistance; MDR, multi-drug resistant; XDR, eXtensive Drug Resistance; OR, odds ratio; HR, hazard ratio; p, the threshold of statistical significance; ESBL, extended spectrum beta-lactamase.